Chargement en cours...
Anti- c-myc cholesterol based lipoplexes as onco-nanotherapeutic agents in vitro
Background: Strategies aimed at inhibiting the expression of the c-myc oncogene could provide the basis for alternative cancer treatment. In this regard, silencing c-myc expression using small interfering RNA (siRNA) is an attractive option. However, the development of a clinically viable, siRNA-bas...
Enregistré dans:
| Publié dans: | F1000Res |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
F1000 Research Limited
2021
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7745184/ https://ncbi.nlm.nih.gov/pubmed/33391729 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/f1000research.25142.2 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|